Literature DB >> 7122055

Reversal of retinal and optic disc ischemia in a patient with sickle cell trait and glaucoma secondary to traumatic hyphema.

M B Wax, M E Ridley, L E Magargal.   

Abstract

A 14-year-old black boy with sickle cell trait, who sustained a traumatic hyphema, developed moderately elevated intraocular pressure that failed to respond to carbonic anhydrase inhibitors and osmotic agents. On the tenth postinjury day, a sudden increased cupping of the optic disc and partial central retinal artery obstruction caused painless loss of vision. Reversal of the cupping, the retinal ischemia, and the intraocular pressure was documented following anterior chamber paracentesis, and visual acuity returned to 6/6. Pathophysiology of the posterior ischemia is discussed. This case documents the potentially debilitating course of traumatic hyphema in "benign" sickle cell trait and its avoidance with proper management. The authors endorse recent suggestions for careful observation of any sickle cell patient with traumatic hyphema, and recommend anterior chamber paracentesis, supplemental oxygen, and avoidance of osmotic agents, if secondary glaucoma develops following the initial trauma.

Entities:  

Mesh:

Year:  1982        PMID: 7122055     DOI: 10.1016/s0161-6420(82)34715-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Central retinal artery occlusion and traumatic optic neuropathy following blunt ocular trauma.

Authors:  Jasmin Zvorničanin; Ferenc Kuhn; Meliha Halilbašić; Zlatko Mušanović
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

2.  A new management system for glaucoma based on improvement of the appearance of the optic disc or visual field.

Authors:  G L Spaeth; R L Fellman; R L Starita; L J Katz; E M Poryzees
Journal:  Trans Am Ophthalmol Soc       Date:  1985

3.  Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute.

Authors:  Tahreem Mir; Mustafa Iftikhar; Natalie Seidel; Michelle Trang; Morton F Goldberg; Fasika A Woreta
Journal:  Clin Ophthalmol       Date:  2020-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.